Targeted disruption of the mouse topoisomerase I gene by camptothecin selection

Molecular and Cellular Biology

Volumn 16, Issue 12, 1996, Pages 6804-6809

  Morham, Scott G ^a   Kluckman, Kimberly D ^a   Voulomanos, Nectarios ^a   Smithies, Oliver ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAMPTOTHECIN; DNA TOPOISOMERASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL CLONE; CELL DIVISION; CELL GROWTH; CELL SELECTION; CONTROLLED STUDY; EMBRYO; EMBRYO CELL; FEMALE; FERTILIZATION; GENE DISRUPTION; GENE EXPRESSION; GENE LOCUS; GENE TARGETING; GENETIC LINKAGE; MALE; MOUSE; NONHUMAN; OOCYTE; PRIORITY JOURNAL; SPERM;

AGOUTI; ANIMALIA;

EID: 0029912651     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.12.6804     Document Type: Article

References (45)

1. Baumgartner, B., C. Klett, H. Hameister, A. Richter, and R. Knippers. 1994. Mouse genes encoding DNA topoisomerase I. Mamm. Genome 5:19-25.
2. Bjornsti, M., P. Benedetti, G. A. Viglianti, and J. C. Wang. 1989. Expression of human DNA topoisomerase 1 in yeast cells lacking yeast DNA topoisomerase I: restoration of sensitivity of the cells to the antitumor drug camptothecin. Cancer Res. 49:6318-6323.
3. Burris, H. A., and S. M. Fields. 1994. Topoisomerase I inhibitors: an overview of the camptothecin analogs. Hematol. Oncol. Clin. N. Am. 8:333-355.
4. D'Arpa, P. D., P. S. Machlin, H. Ratrie, N. F. Rothfield, D. W. Cleveland, and W. C. Earnshaw. 1988. cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7 kDa carboxyl-terminal fragment. Proc. Natl. Acad. Sci. USA 85:2543-2547.
5. Di Mauro, E., G. Camilloni, L. Verdone, and M. Caserta. 1993. DNA topoisomerase I controls the kinetics of promoter activation and DNA topology in Saccharomyces cerevisiae. Mol. Cell. Biol. 13:6702-6710.
6. Dinardo, S., K. A. Voelkel, R. Sternglanz, A. E. Reynolds, and A. Wright. 1982. Escherichia coli DNA topoisomerase I mutants have compensatory mutations in DNA gyrase genes. Cell 31:43-51.
7. Dubrez, L., F. Goldwasser, P. Genne, Y. Pommier, and E. Solary. 1995. The role of cell cycle regulation and apoptosis triggering in determining the sensitivity of leukemic cells to topoisomerase I and II inhibitors. Leukemia 9:1013-1024.
8. Gilmour, D. S., G. Pflugfelder, J. C. Wang, and J. T. Lis. 1986. Topoisomerase I interacts with transcribed regions in Drosophila cells. Cell 44:401-407.
9. Giovanella, B. C., J. S. Stehlin, M. E. Wall, M. C. Wani, A. W. Nicholas, L. F. Liu, and M. Potmesil. 1989. DNA topoisomerase I-targeted chemotherapy of human colon cancer in xenografts. Science 246:1046-1048.
10. Hooper, M., K. Hardy, A. Handyside, S. Hunter, and M. Monk. 1987. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature (London) 336:348-352.
11. Hsiang, Y. H., R. Hertzberg, S. Hecht, and L. F. Liu. 1985. Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J. Biol. Chem. 260:14873-14878.
12. Ishimi, Y., K. Sugasawa, F. Hanaoka, and A. Kikuchi. 1991. Replication of the simian virus 40 chromosome with purified proteins. J. Biol. Chem. 266: 16141-16148.
13. Kijama, T., N. Kubola, and K. Nishio. 1994. Establishment of a CPT-11-resistant human ovarian cancer cell line. Anticancer Res. 14(Suppl. 3A):799-803.
14. Kim, H. S., and O. Smithies. 1988. Recombinant fragment assay for gene targeting based on the polymerase chain reaction. Nucleic Acids Res. 162: 8887-8903.
15. Kim, R. A., and J. C. Wang. 1989. Function of DNA topoisomerases as replication swivels in Saccharomyces cerevisiae. J. Mol. Biol. 208:257-267.
16. Koiwai, O., Y. Yasui, Y. Sakai, T. Watanabe, K. Ishii, S. Yanagihara, and T. Andoh. 1993. Cloning of the mouse cDNA encoding DNA topoisomerase I and chromosomal location of the gene. Gene 125:211-216.
17. Kondo, K., K. Tsuneizumi, T. Watanabe, and M. Oishi. 1991. Induction of in vitro differentiation of mouse embryonal carcinoma (F9) cells by inhibitors of topoisomerases. Cancer Res. 51:5398-5404.
18. Kretzschmar, M., M. Meisterernst, and R. G. Roeder. 1993. Identification of human DNA topoisomerase I as a cofactor for activator-dependent transcription by RNA polymerase II. Proc. Natl. Acad. Sci. USA 90:11508-11512.
19. Kubota, N., F. Kanzawa, K. Nishio, Y. Takeda, T. Ohmori, Y. Fujiwara, Y. Terashima, and N. Saijo. 1992. Detection of a topoisomerase I gene point mutation in a CPT-11 resistant lung cancer cell line. Biochem. Biophys. Res. Commun. 188:571-577.
20. Kunze, N., G. Yang, M. Dolberg, R. Sundarp, R. Knippers, and A. Richter. 1991. Structure of the human type I DNA topoisomerase gene. J. Biol. Chem. 266:9610-9616.
21. Lee, M. P., S. D. Brown, A. Chen, and T. S. Hsieh. 1993. DNA topoisomerase is essential in Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 90:6656-6660.
22. Loenen, W. A. M., and F. R. Blattner. 1983. Lambda Charon vectors (ch32, 33, 34 and 35) adapted for DNA cloning in recombination-deficient hosts. Gene 26:171-179.
23. Mansour, S. L., K. R. Thomas, and M. R. Capecchi. 1988. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature (London) 336:348-352.
24. Morham, S. Unpublished results.
25. Morham, S. G., and S. Shuman. 1993. Covalent and noncovalent DNA binding by mutants of vaccinia DNA topoisomerase I. J. Biol. Chem. 267: 15984-15992.
26. Mortenson, R. M., M. Zubiar, E. J. Neer, and J. G. Seidman. 1991. Embryonic stem cells lacking a functional inhibitory G-protein subunit (alpha i2) produced by gene targeting of both alleles. Proc. Natl. Acad. Sci. USA 88:7036-7040.
27. Porter, S. E., and J. J. Champoux. 1989. The basis for camptothecin enhancement of DNA breakage by eukaryotic topoisomerase I. Nucleic Acids Res. 17:8521-8532.
28. Potmesil, M., Y. H. Hsiang, L. F. Liu, B. Bank, H. Grossberg, S. Kirschenbaum, T. J. Forlenza, A. Penziner, D. Kanganis, D. Knowles, F. Traganos, and R. Silber. 1988. Resistance of human leukemic and normal lymphocytes to drug-induced DNA cleavage and low levels of DNA topoisomerase II. Cancer Res. 48:3537-3543.
29. Pruss, G. J., S. H. Manes, and K. Drlica. 1982. Escherichia coli DNA topoisomerase I mutants: increased supercoiling is corrected by mutations near gyrase genes. Cell 31:35-42.
30. Raji, A., D. J. Zabel, C. S. Laufer, and R. E. Depew. 1985. Genetic analysis of mutations that compensate for loss of Escherichia coli DNA topoisomerase I. J. Bacteriol. 162:1173-1179.
31. Ryan, A. J., S. Squires, H. L. Strutt, and R. T. Johnson. 1991 Camptothecin cytotoxicity in mammalian cells is associated with the induction of persistent double strand breaks in the replicating DNA. Nucleic Acids Res. 19:3295-3300.
32. Sambrook, J., E. F. Fritsch, and T. Manialis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
33. Simerly, C., and G. Schatten. 1993. Guide to techniques in mouse development. Methods Enzymol. 225:519-522.
34. Sorenson, M., M. Sehested, and P. B. Jensen. 1995. Characterization of a human small-cell lung cancer cell line resistant to the DNA topoisomerase I-directed drug topotecan. Br. J. Cancer 73:399-404.
35. Stewart, A. F., R. E. Herrera, and A. Nordheim. 1990. Rapid induction of c-fos transcription reveals quantitative linkage of RNA polymerase II and DNA topoisomerase I enzyme activities. Cell 60:141-149.
36. Stewart, A. F., and G. Schutz. 1987. Camptothecin-induced in vivo topoisomerase I cleavages in the transcriptionally active tyrosine aminotransferase gene. Cell 50:1109-1117.
37. Tanizawa, A., R. Beitrand, G. Kohlhagen, A. Tabuchi, J. Jenkins, and Y. Pommier. 1993. Cloning of Chinese hamster DNA topoisomerase 1 cDNA and identification of a single point mutation responsible for camptothecin resistance. J. Biol. Chem. 268:25463-25468.
38. Tanizawa, A., and Y. Pommier. 1992. Topoisomerase I alteration in a camptothecin-resistant cell line derived from Chinese hamster DC3F cells in culture. Cancer Res. 52:1848-1854.
39. Thrash, C., A. T. Bankier, B. G. Barrell, and R. Sternglanz. 1985. Cloning, characterization, and sequence of the yeast DNA topoisomerase gene. Proc. Natl. Acad. Sci. USA 82:4374-4378.
40. Uemura, T., and M. Yanagida. 1984. Isolation of type I and II DNA topoisomerase mutants from fission yeast: single and double mutants show different phenotypes in cell growth and chromatin organization. EMBO J. 3:1737-1744.
41. Vosberg, H. P. 1985. DNA topoisomerases: enzymes that control DNA conformation. Curr. Top. Microbiol. Immunol. 114:19-102.
42. Wang, J. C. 1987. Recent studies of DNA topoisomerases. Biochim. Biophys. Acta 909:1-9.
43. Wobbe, C. R., F. B. Dean, Y. Murakami, J. A. Borowiec, P. Bullock, and J. Hurwitz. 1987. In vitro replication of DNA containing either the SV40 or the polyoma origin. Philos. Trans. R. Soc. Lond. 8317:439-453.
44. Wold, M. S., D. H. Weinberg, D. M. Virshup, J. J. Li, and T. J. Kelly. 1989. Identification of cellular proteins required for simian virus 40 DNA replication. J. Biol. Chem. 264:2801-2809.
45. Woychick, R. P., W. M. Generoso, L. B. Russell, K. T. Cain, N. L. A. Cacheiro, S. J. Bultman, P. B. Selby, M. E. Dickinson, B. L. M. Hogan, and J. C. Rutledge. 1990. Molecular and genetic characterization of a radiation-induced structural rearrangement in mouse chromosome 2 causing mutations at the limb deformity and agouti loci. Proc. Natl. Acad. Sci. USA 87: 2588-2592.